BY AND BETWEEN NOVARTIS GENE THERAPIES SWITZERLAND GMBH ANDInterventional Trial Agreement • December 17th, 2020
WHEREAS, the Sponsor has proposed and is willing to undertake a clinical study known as NEONATAL SCREENING TO THE EARLY DETECTION OF PATIENTS WITH SPINAL MUSCULAR ATROPHY AND INMUNODEFICIENCIES ( Study
